ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

Transcription

1 ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES: To outline the division and delegation of responsibilities and clarify boundaries of responsibility within the research study team and how they should be documented. POLICY AUTHOR: Katie Helm; Research & Development Facilitator Page 1 of

2 BACKGROUND Appropriately qualified and trained personnel are required to ensure the satisfactory conduct of research studies at a site. This may include staff directly involved in the conduct of the research such as: Principal Investigator (PI) Co-investigator Research practitioners (e.g. research nurses/ practitioners/ officers/ coordinators) Study co-ordinators (e.g. data managers/ research assistants) In addition, there may be staff associated with, but not directly involved in the research study at the site, including: Clinicians and other clinical staff Specialist nurses Pharmacists Other support staff e.g. radiology, laboratory For a study to adhere to Good Clinical Practice (GCP) guidelines, Study Protocol and applicable regulatory requirements, it is essential that all staff involved are aware of their roles and responsibilities and that they are appropriate for the duties delegated to them by the PI. International conference of Harmonisation GCP (ICH GCP) guidelines define an investigator as A person responsible for the conduct of the clinical trial at a trial site. The investigator is responsible for protecting the integrity, health and welfare of the research subjects. The investigator must be: Qualified by education, training and experience Thoroughly familiar with the study protocol and any investigational product(s) Aware of, and compliant with Good Clinical Practice and any applicable regulatory requirements, e.g. Medicines for Human Use (Clinical Trials) Regulations 2004 or Research Governance Framework for health and social care 2005 Page 2 of

3 If a team of investigators conducts a study at a site, the investigator responsible for leading the team is referred to as the PI. Other investigators are referred to as coinvestigators. The Sponsor takes responsibility for the initiation, management and financing (or arranging the financing) of the study. PURPOSE To outline the division and delegation of responsibilities and clarify boundaries of responsibility within the research study team and how they should be documented. PROCEDURE Who? During the study set up, the PI, co-investigator(s) if applicable and the assigned research practitioner to be working on the study must discuss and agree on the study requirements and the delegation of duties. This may need to be conducted with a representative from the sponsor. The delegation of duties will depend on the qualifications and experience of the individuals in the team, and will vary from study to study and from staff member to staff member. Evidence of appropriateness to perform the delegated duties is generally in the form of up to date Curriculum Vitae (CV), and evidence of GCP training (certificate). The PI must be assured by these and knowledge of the study team that all team members are able to perform their delegated duties appropriately. When? The delegation of duties and roles within the study team should be discussed and documented as part of study set up and initiation. Further training and competency may be required by some members of the team which should be undertaken before commencing work on the study. Page 3 of

4 The Principal Investigator may be required to sign off their team on the delegation of duties log as part of the official initiation visit, if appropriate. How Roles of the study team The majority of studies have a PI, who has overall responsibility for the conduct of the study at their site. The responsibilities of a PI are summarised in Appendix A and include: Ensuring the welfare and medical care of study subjects Obtaining approval of and continued communication with regulatory bodies Conduct of the study in compliance with the protocol and required governance regulations and guidelines, as well as local policies/procedures Administration, management, storage of investigational product Safety reporting The accurate and timely completion of study data Archiving Evidence of appropriateness of research team Research Governance Framework for Health and Social Care state that the Chief Investigator is responsible for ensuring that; Each member of the research team, including those at collaborating sites, is qualified by education, training and experience to discharge his/her role in the study, and their qualifications are documented. A current CV for each member of the study team will fulfil this requirement for qualifications to be documented. The CV should be updated every 2 years or when there is a relevant change. Superceded versions should be maintained in the site file. National Research Ethics Service (NRES) (www.nres.nhs.uk) gives guidance on completion of CV for researchers. This training will include study specific required training and experience. Good Clinical Practice (GCP) training should be attended and certificate of attendance will be evidence of this. These documents are essential documents and must be maintained as such within the study site file. Page 4 of

5 The frequency of GCP training must satisfy the Sponsor and Trust requirements. For Lancashire Care NHS Foundation Trust, the suggested timeframe for this is every two years. Clarification should therefore be sought from the study Sponsor. Delegation of duties The clinical trials regulations state: A sponsor of a clinical trial, in accordance with this regulation may delegate any or all of his functions under these regulations to any person but any such arrangement shall not affect the responsibility of the sponsor. The principle of delegation of duties is that the duty can be delegated but not the responsibility. This delegation may be from Sponsor to CI; CI to PI; PI to members of the site study team. At a study site, any duties that are delegated to the study team remain the responsibility of the PI. Each member of the team should perform their delegated duties adhering not only to research guidance and relevant legislation but also to local Trust and professional body requirements. Other key staff involved in the study may be delegated duties by the PI. A summary of some of these duties is shown in Appendix B however full details will be listed in each study protocol. These people must be appropriately experienced and qualified to assist in the management of the study for the task that they have been delegated. The PI can delegate duties, but never the responsibility for the study at the site. The allocation of duties to appropriately qualified persons should be recorded in a study specific delegation of duties log (Appendix C) with specimen signatures and the initials of all involved. The Sponsor may provide their own template to be used. If a large number of clinical staff are involved in a routine part of the study and their duties, e.g. delivering a study drug over many weeks, it may be more practical to include the senior staff member responsible for their conduct in the log, e.g. ward sister, rather than every single staff member. This must be agreed with the sponsor. Page 5 of

6 Documentation of delegated duties is an on-going process as circumstances may change, e.g. different members of staff may become involved in the study. The log must: List the names and roles of all staff involved and outline which duties have been delegated to them Confirm the start and end dates for each member of staff performing their delegated duties Be signed and dated by the PI they should sign off each individual member of staff, considering their evidence of training, education and experience prior to the staff member carrying out any duties for the trial. By delegating duties the PI confirms that the team member is appropriate for their delegated duties. and maintain the responsibility. Therefore active involvement in the study is not permitted for staff until they have been signed off by the PI. Be updated throughout the study. This may include new staff and staff who leave. Superseded versions must not be destroyed in order to allow an audit trail of who was performing which duties at any time point in the conduct of the study for future inspection Be filed appropriately in the Investigator Site File. If archived by a sponsor, a copy must remain at the site Be supplied to the sponsor as requested, with updated versions being supplied when updated. Contact names and roles of other individuals involved in the study (e.g. pharmacy, laboratory staff) should also be notified to the sponsor. The delegation of duties log is an essential document and must be maintained as such within the study site file. OTHER RELATED PROCEDURES, POLICIES, LEGISLATION OR GUIDANCE International Conference on Harmonisation of Good Clinical Practice 1996 Department of Health Research Governance Framework for Health and Social Care 2005 Page 6 of

A robust feasibility is an essential part of ensuring study delivery. Please pass this Study Feasibility Assessment and a copy of the Protocol to the individual(s) who are most appropriate to accurately

v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,

Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

Guidance to Research Ethics Committees on Initial Facility Assessment Introduction One of the roles of a Research Ethics Committee is to provide an opinion on a proposed study, based on the suitability

This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

Application package to HRA Before submitting your application, please review the information about the standards against which the HRA will review applications in HRA assessment: http://www.hra.nhs.uk/resources/hra-approval-applicant-guidance/hra-assessmentcriteria-and-standards/

Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how

CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE Loughborough University (LU) Research Office SOP 1033 LU Process for Assessing Site Feasibility for NHS Research Sponsored by Loughborough

Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices

MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR

Trial Management Workstream 4: Trial Management and Monitoring: B) Summary of Trial Management Systems (TMS) Trial management is the process of ensuring that a trial is run effectively and within budget.

Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed

Protocol Deviations, Non-Compliance Clinical Trials SOP Reference ID: Noclor/Spon/S10/01 Version Number 1.0 Effective Date: 1 st March 2016 It is the responsibility of all users of this SOP to ensure that

The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark Question 1: What laws or regulations apply to an application for conducting a clinical

Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor

Site Level Feasibility Assessment Guidance What is a feasibility assessment? Feasibility is a process of comprehensive analysis and planning, including risk assessment and contingency planning. Aims of

Title: Outcome Statement: Research Study Close-down and Archiving Procedures To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.

Site Specific Information Form Completion The IMPROVE ethics application has been received by England and Scotland ethics committees. We now need to submit a Site Specific Information form (SSI) for each

Essential Documents for Clinical Trial Research Erin Cherban, MSc., CCRP Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office Document Examples See the following

Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Undertaking Risk Assessment of a Research and Development Project SOP Number: 33 Version Number: 1.0 Supercedes: N/A Effective

Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal

CHANGE SUMMARY: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. Key changes to the policy require all sites to submit a bi-annual Clinical

This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,

703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a

: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place

LIVERPOOL JOHN MOORES UNIVERSITY SPONSORSHIP OF RESEARCH PROJECTS UNDER THE RESEARCH GOVERNANCE FRAMEWORK FOR HEALTH AND SOCIAL CARE April 2015 1 Background The Department of Health s Research Governance

An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,

10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular